Stocks›Healthcare

Molbio Diagnostics Limited

MOLBIO · NSE · Healthcare · As of 8 Nov 2026

₹1,360.20

+₹20.90 (+1.56%)(1D)

₹926.35Since listing range₹1,686.80

Market Cap

—

P/E (Sector)

92.1 (32.3)

P/B Ratio

—

Dividend Yield

—

ROE

12.5%

Debt / Equity

0.32

Anvest Score

52/100

Valuation

30/100

Quality

56/100

Growth

39/100

Health

90/100

Momentum

—

Omitted

Valuation
30
Quality
56
Growth
39
Health
90
Momentum
—

AI Company ProfileFiling-backed

AI Snapshot

It was incorporated as Molbio Diagnostics Private Limited on October 20, 2000. Company facts on this page are read from the offer document registered with SEBI; operating history will build up from the company's own filings from its first reporting quarter onwards.

Medical Equipment & SuppliesFounded:2000CEO/MD:Sriram NatarajanHQ:Plot No. L-46, Phase II-D, Verna Industrial Area, Verna, Salcete, South Goa 403 722, Goa, India

Business profile as of period ended 16 Oct 2026

Business at a Glance

Operates in a molecular diagnostic industry characterized by extensive R&D.
Faces competition primarily from centralized laboratories and diagnostic companies.

Revenue growth: +41.7%FY26 growth
PAT growth: +18.4%FY26 growth
CFO / PAT: 0.31×FY26

What Looks Strong

IPOShares trade +68.6% above the ₹807 IPO issue price.

What to Watch

MarginsOperating margin compressed from ~21.3% to ~17.8% in FY26 (consolidated). Watch input costs and pricing in the next two results.
Cash FlowOperating cash flow was only 0.3× reported net profit in FY26 (consolidated), a divergence worth watching for receivables or inventory build-up.
ValuationThe shares trade at 92× trailing earnings; the multiple assumes sustained high growth and is sensitive to any slowdown.
HistoryShort public market track record with limited historical filing cycles.

Loading company profile…

Fundamentals

P/E Ratio (TTM)

92.09

Sector median P/E

32.29

P/B Ratio

—

Sector median P/B

4.4

EPS (TTM)

₹14.77

ROE

12.54%

ROCE

15.37%

Profit Margin

11.28%

Debt/Equity

0.32

Molbio Diagnostics Limited FAQs

3 topics

Expand

What does the Molbio Diagnostics Limited (MOLBIO) stock page cover?

Molbio Diagnostics Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.

What are the current headline metrics for MOLBIO?

Molbio Diagnostics Limited is currently shown with a delayed price near ₹1,360.2, P/E 92.09, and ROE 12.54%.

Does the MOLBIO page provide investment advice?

No. The MOLBIO page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.

Keep exploring